Viveve Medical, Inc. (VIVE)
USD 0.0
(100.0%)
USD 0.0
(100.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2021 | -21.55 Million USD | -16.53% |
| 2020 | -18.49 Million USD | 38.22% |
| 2019 | -29.93 Million USD | 33.42% |
| 2018 | -44.96 Million USD | -33.31% |
| 2017 | -33.73 Million USD | -80.34% |
| 2016 | -18.7 Million USD | -56.0% |
| 2015 | -11.99 Million USD | -111.76% |
| 2014 | -5.66 Million USD | -20.37% |
| 2013 | -4.7 Million USD | -14.04% |
| 2012 | -4.12 Million USD | -20.9% |
| 2011 | -3.41 Million USD | -465.84% |
| 2010 | -603 Thousand USD | 62.98% |
| 2009 | -1.62 Million USD | 22.76% |
| 2008 | -2.1 Million USD | 24.87% |
| 2007 | -2.8 Million USD | -409.14% |
| 2006 | 908 Thousand USD | 159.89% |
| 2005 | -1.51 Million USD | -58.74% |
| 2004 | -955 Thousand USD | -233.75% |
| 2003 | 714 Thousand USD | 209.09% |
| 2002 | 231 Thousand USD | 105.56% |
| 2001 | -4.15 Million USD | 46.78% |
| 2000 | -7.8 Million USD | -15.33% |
| 1999 | -6.76 Million USD | 60.43% |
| 1998 | -17.1 Million USD | -17.12% |
| 1997 | -14.6 Million USD | -630.0% |
| 1996 | -2 Million USD | -242.86% |
| 1995 | 1.4 Million USD | 148.28% |
| 1994 | -2.9 Million USD | 30.95% |
| 1993 | -4.2 Million USD | -27.27% |
| 1992 | -3.3 Million USD | -73.68% |
| 1991 | -1.9 Million USD | -1800.0% |
| 1990 | -100 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 Q3 | -4.66 Million USD | 7.13% |
| 2022 Q2 | -5.02 Million USD | 8.28% |
| 2022 Q1 | -5.47 Million USD | 8.59% |
| 2021 Q2 | -4.94 Million USD | 3.59% |
| 2021 Q3 | -5.49 Million USD | -11.06% |
| 2021 Q4 | -5.98 Million USD | -9.01% |
| 2021 FY | -21.55 Million USD | -16.53% |
| 2021 Q1 | -5.12 Million USD | -18.64% |
| 2020 Q3 | -3.4 Million USD | 31.11% |
| 2020 Q1 | -5.82 Million USD | 17.38% |
| 2020 Q2 | -4.94 Million USD | 15.21% |
| 2020 Q4 | -4.32 Million USD | -27.0% |
| 2020 FY | -18.49 Million USD | 38.22% |
| 2019 Q3 | -6.52 Million USD | 21.55% |
| 2019 Q1 | -8.77 Million USD | 28.46% |
| 2019 Q4 | -7.05 Million USD | -8.04% |
| 2019 Q2 | -8.32 Million USD | 5.2% |
| 2019 FY | -29.93 Million USD | 33.42% |
| 2018 Q3 | -11.06 Million USD | -7.45% |
| 2018 Q1 | -11.34 Million USD | -20.27% |
| 2018 Q2 | -10.29 Million USD | 9.22% |
| 2018 FY | -44.96 Million USD | -33.31% |
| 2018 Q4 | -12.26 Million USD | -10.9% |
| 2017 Q1 | -6.41 Million USD | -16.04% |
| 2017 FY | -33.73 Million USD | -80.34% |
| 2017 Q4 | -9.42 Million USD | -6.88% |
| 2017 Q3 | -8.82 Million USD | 2.66% |
| 2017 Q2 | -9.06 Million USD | -41.26% |
| 2016 Q3 | -4.63 Million USD | -2.0% |
| 2016 Q4 | -5.52 Million USD | -19.29% |
| 2016 Q1 | -3.99 Million USD | -12.12% |
| 2016 Q2 | -4.54 Million USD | -13.71% |
| 2016 FY | -18.7 Million USD | -56.0% |
| 2015 Q2 | -2.88 Million USD | -18.61% |
| 2015 Q3 | -3.1 Million USD | -7.55% |
| 2015 Q1 | -2.43 Million USD | -46.64% |
| 2015 FY | -11.99 Million USD | -111.76% |
| 2015 Q4 | -3.56 Million USD | -14.78% |
| 2014 Q3 | -2.35 Million USD | -98.13% |
| 2014 FY | -5.66 Million USD | -20.37% |
| 2014 Q1 | -973 Thousand USD | 9.82% |
| 2014 Q2 | -1.19 Million USD | -22.4% |
| 2014 Q4 | -1.65 Million USD | 29.66% |
| 2013 Q3 | -1.27 Million USD | 1.24% |
| 2013 Q1 | -1.07 Million USD | -19.55% |
| 2013 FY | -4.7 Million USD | -14.04% |
| 2013 Q4 | -1.07 Million USD | 15.04% |
| 2013 Q2 | -1.28 Million USD | -20.19% |
| 2012 Q3 | -1.09 Million USD | -13.35% |
| 2012 Q2 | -966 Thousand USD | 17.37% |
| 2012 Q1 | -1.16 Million USD | 71.64% |
| 2012 FY | -4.12 Million USD | -20.9% |
| 2012 Q4 | -895 Thousand USD | 18.26% |
| 2011 Q4 | -4.12 Million USD | -361.59% |
| 2011 FY | -3.41 Million USD | -465.84% |
| 2011 Q2 | -840 Thousand USD | 34.32% |
| 2011 Q1 | -1.27 Million USD | -889.51% |
| 2011 Q3 | -893 Thousand USD | -6.31% |
| 2010 FY | -603 Thousand USD | 62.98% |
| 2010 Q3 | -5000.00 USD | 97.49% |
| 2010 Q1 | -561 Thousand USD | 6.97% |
| 2010 Q2 | -199 Thousand USD | 64.53% |
| 2010 Q4 | 162 Thousand USD | 3340.0% |
| 2009 Q3 | -359 Thousand USD | -16.56% |
| 2009 Q1 | -359 Thousand USD | -54.74% |
| 2009 Q4 | -603 Thousand USD | -67.97% |
| 2009 FY | -1.62 Million USD | 22.76% |
| 2009 Q2 | -308 Thousand USD | 14.21% |
| 2008 Q1 | -815 Thousand USD | 11.7% |
| 2008 FY | -2.1 Million USD | 24.87% |
| 2008 Q4 | -232 Thousand USD | 36.61% |
| 2008 Q3 | -366 Thousand USD | 47.41% |
| 2008 Q2 | -696 Thousand USD | 14.6% |
| 2007 FY | -2.8 Million USD | -409.14% |
| 2007 Q4 | -923 Thousand USD | -52.81% |
| 2007 Q2 | -475 Thousand USD | 40.99% |
| 2007 Q1 | -805 Thousand USD | -1138.46% |
| 2007 Q3 | -604 Thousand USD | -27.16% |
| 2006 Q2 | -41 Thousand USD | -103.37% |
| 2006 FY | 908 Thousand USD | 159.89% |
| 2006 Q1 | 1.21 Million USD | 363.42% |
| 2006 Q4 | -65 Thousand USD | 67.98% |
| 2006 Q3 | -203 Thousand USD | -395.12% |
| 2005 FY | -1.51 Million USD | -58.74% |
| 2005 Q4 | -462 Thousand USD | 0.43% |
| 2005 Q3 | -464 Thousand USD | -31.07% |
| 2005 Q1 | -236 Thousand USD | -218.0% |
| 2005 Q2 | -354 Thousand USD | -50.0% |
| 2004 Q3 | -446 Thousand USD | -33.93% |
| 2004 Q2 | -333 Thousand USD | 11.44% |
| 2004 Q1 | -376 Thousand USD | -221.68% |
| 2004 FY | -955 Thousand USD | -233.75% |
| 2004 Q4 | 200 Thousand USD | 144.84% |
| 2003 Q2 | 192 Thousand USD | 4900.0% |
| 2003 FY | 714 Thousand USD | 209.09% |
| 2003 Q3 | 217 Thousand USD | 13.02% |
| 2003 Q4 | 309 Thousand USD | 42.4% |
| 2003 Q1 | -4000.00 USD | -102.21% |
| 2002 Q4 | 181 Thousand USD | -11.27% |
| 2002 FY | 231 Thousand USD | 105.56% |
| 2002 Q3 | 204 Thousand USD | 70.0% |
| 2002 Q2 | 120 Thousand USD | 143.8% |
| 2002 Q1 | -274 Thousand USD | 56.16% |
| 2001 Q4 | -625 Thousand USD | 40.13% |
| 2001 Q3 | -1.04 Million USD | 13.5% |
| 2001 Q2 | -1.2 Million USD | 5.48% |
| 2001 Q1 | -1.27 Million USD | 58.7% |
| 2001 FY | -4.15 Million USD | 46.78% |
| 2000 Q1 | -2.28 Million USD | -66.91% |
| 2000 Q2 | -997 Thousand USD | 56.27% |
| 2000 Q3 | -1.43 Million USD | -43.83% |
| 2000 Q4 | -3.09 Million USD | -115.62% |
| 2000 FY | -7.8 Million USD | -15.33% |
| 1999 Q4 | -1.36 Million USD | 8.93% |
| 1999 Q3 | -1.5 Million USD | 21.05% |
| 1999 Q2 | -1.9 Million USD | 13.64% |
| 1999 Q1 | -2.2 Million USD | 35.29% |
| 1999 FY | -6.76 Million USD | 60.43% |
| 1998 Q1 | -4.1 Million USD | 21.15% |
| 1998 Q3 | -4 Million USD | 27.27% |
| 1998 Q4 | -3.4 Million USD | 15.0% |
| 1998 FY | -17.1 Million USD | -17.12% |
| 1998 Q2 | -5.5 Million USD | -34.15% |
| 1997 Q2 | -2.7 Million USD | 12.9% |
| 1997 Q3 | -3.6 Million USD | -33.33% |
| 1997 FY | -14.6 Million USD | -630.0% |
| 1997 Q1 | -3.1 Million USD | -106.67% |
| 1997 Q4 | -5.2 Million USD | -44.44% |
| 1996 Q1 | 1.1 Million USD | 124.44% |
| 1996 Q4 | -1.5 Million USD | -114.29% |
| 1996 Q3 | -700 Thousand USD | 41.67% |
| 1996 Q2 | -1.2 Million USD | -209.09% |
| 1996 FY | -2 Million USD | -242.86% |
| 1995 Q2 | 1.5 Million USD | -48.28% |
| 1995 Q3 | 1.6 Million USD | 6.67% |
| 1995 Q4 | -4.5 Million USD | -381.25% |
| 1995 Q1 | 2.9 Million USD | 680.0% |
| 1995 FY | 1.4 Million USD | 148.28% |
| 1994 Q1 | -700 Thousand USD | 36.36% |
| 1994 FY | -2.9 Million USD | 30.95% |
| 1994 Q3 | -1.1 Million USD | -57.14% |
| 1994 Q4 | -500 Thousand USD | 54.55% |
| 1994 Q2 | -700 Thousand USD | 0.0% |
| 1993 Q4 | -1.1 Million USD | -10.0% |
| 1993 FY | -4.2 Million USD | -27.27% |
| 1993 Q1 | -900 Thousand USD | 18.18% |
| 1993 Q2 | -1.2 Million USD | -33.33% |
| 1993 Q3 | -1 Million USD | 16.67% |
| 1992 Q4 | -1.1 Million USD | -83.33% |
| 1992 Q1 | -800 Thousand USD | 60.0% |
| 1992 Q3 | -600 Thousand USD | 33.33% |
| 1992 Q2 | -900 Thousand USD | -12.5% |
| 1992 FY | -3.3 Million USD | -73.68% |
| 1991 Q4 | -2 Million USD | -2100.0% |
| 1991 Q2 | 100 Thousand USD | 0.0% |
| 1991 Q3 | 100 Thousand USD | 0.0% |
| 1991 Q1 | 100 Thousand USD | 200.0% |
| 1991 FY | -1.9 Million USD | -1800.0% |
| 1990 FY | -100 Thousand USD | 0.0% |
| 1990 Q3 | 100 Thousand USD | 0.0% |
| 1990 Q2 | 100 Thousand USD | 0.0% |
| 1990 Q1 | 100 Thousand USD | 0.0% |
| 1990 Q4 | -100 Thousand USD | -200.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -50.08% |
| Cerus Corporation | -30.05 Million USD | 28.283% |
| OrthoPediatrics Corp. | -25.76 Million USD | 16.351% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -102.922% |
| Talis Biomedical Corporation | -66.81 Million USD | 67.742% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -24.613% |
| Inogen, Inc. | -109.38 Million USD | 80.296% |
| Spectral AI, Inc. | -12.98 Million USD | -65.997% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 65.564% |
| CVRx, Inc. | -43.1 Million USD | 49.997% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -510.913% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -73.423% |
| Orthofix Medical Inc. | -139.11 Million USD | 84.507% |
| Venus Concept Inc. | -28.3 Million USD | 23.865% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 60.108% |
| Bioventus Inc. | -81.72 Million USD | 73.627% |
| BrainsWay Ltd. | -4.92 Million USD | -337.447% |
| Envoy Medical, Inc. | -18.37 Million USD | -17.321% |
| electroCore, Inc. | -18.8 Million USD | -14.613% |
| IceCure Medical Ltd | -15.57 Million USD | -38.373% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 55.544% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -24.814% |
| MaxCyte, Inc. | -48.29 Million USD | 55.376% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -80.281% |
| Nexalin Technology, Inc. | -5.69 Million USD | -278.369% |
| PAVmed Inc | -68.79 Million USD | 68.671% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 61.896% |
| RxSight, Inc. | -50.08 Million USD | 56.967% |
| Sight Sciences, Inc. | -57.27 Million USD | 62.369% |
| SI-BONE, Inc. | -46.93 Million USD | 54.075% |
| TELA Bio, Inc. | -44.07 Million USD | 51.099% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 60.198% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 58.091% |
| LivaNova PLC | -68.49 Million USD | 68.535% |
| 908 Devices Inc. | -42.75 Million USD | 49.593% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 87.57% |
| Nemaura Medical Inc. | -9.59 Million USD | -124.622% |
| NeuroPace, Inc. | -27.17 Million USD | 20.685% |
| LENSAR, Inc. | -12.22 Million USD | -76.245% |
| Apyx Medical Corporation | -17.25 Million USD | -24.88% |
| Cutera, Inc. | -156.23 Million USD | 86.204% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -150.5% |
| BioSig Technologies, Inc. | -28.51 Million USD | 24.407% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 75.407% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 3.978% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 119.326% |
| Axonics, Inc. | -26.05 Million USD | 17.285% |
| Outset Medical, Inc. | -169.77 Million USD | 87.305% |
| IRIDEX Corporation | -10 Million USD | -115.379% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 80.257% |
| IRadimed Corporation | 20.03 Million USD | 207.574% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -161.407% |
| INVO Bioscience, Inc. | -6.76 Million USD | -218.494% |
| Telesis Bio, Inc. | -35.15 Million USD | 38.683% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 250.405% |
| Varex Imaging Corporation | 32.1 Million USD | 167.143% |
| Quipt Home Medical Corp. | 3.91 Million USD | 649.962% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -77.639% |
| Pulmonx Corporation | -61.93 Million USD | 65.201% |
| Dynatronics Corporation | -2.27 Million USD | -848.198% |
| Modular Medical, Inc. | -17.52 Million USD | -22.956% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -47.23% |
| Semler Scientific, Inc. | 22.25 Million USD | 196.841% |
| InMode Ltd. | 195.66 Million USD | 111.016% |
| Bruker Corporation | 436.9 Million USD | 104.933% |
| Cytosorbents Corporation | -31.2 Million USD | 30.94% |
| DexCom, Inc. | 597.7 Million USD | 103.606% |
| Align Technology, Inc. | 643.33 Million USD | 103.35% |
| ZimVie Inc. | -30.93 Million USD | 30.337% |
| Movano Inc. | -29.69 Million USD | 27.407% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 22.597% |
| Nexalin Technology, Inc. | -5.69 Million USD | -278.369% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -510.913% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 90.759% |
| Profound Medical Corp. | -28.61 Million USD | 24.682% |
| Insulet Corporation | 220 Million USD | 109.797% |
| enVVeno Medical Corporation | -25.23 Million USD | 14.601% |
| Surmodics, Inc. | -5.64 Million USD | -281.807% |
| iCAD, Inc. | -7.68 Million USD | -180.31% |
| Nuwellis, Inc. | -17.63 Million USD | -22.252% |
| Biotricity, Inc. | -8.82 Million USD | -144.136% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 82.78% |
| Aethlon Medical, Inc. | -12.63 Million USD | -70.561% |
| InspireMD, Inc. | -21.14 Million USD | -1.939% |
| PAVmed Inc. | -68.79 Million USD | 68.671% |
| BIOLASE, Inc. | -17.93 Million USD | -20.159% |
| Beyond Air, Inc. | -63 Million USD | 65.792% |
| FONAR Corporation | 16.53 Million USD | 230.345% |
| AxoGen, Inc. | -21.46 Million USD | -0.424% |
| Vivani Medical, Inc. | -26.96 Million USD | 20.07% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 219.467% |
| Inari Medical, Inc. | -14.03 Million USD | -53.599% |
| UFP Technologies, Inc. | 57.66 Million USD | 137.377% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -337.393% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -241.798% |
| Tenon Medical, Inc. | -15.72 Million USD | -37.045% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -188.373% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 49.532% |
| AdaptHealth Corp. | -598.4 Million USD | 96.398% |
| Sintx Technologies, Inc. | -13.35 Million USD | -61.349% |
| NanoVibronix, Inc. | -3.43 Million USD | -527.27% |
| Quanterix Corporation | -49.7 Million USD | 56.635% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -77.639% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -5542.147% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 93.556% |
| TransMedics Group, Inc. | -28.72 Million USD | 24.973% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 8.72% |
| NeuroMetrix, Inc. | -7.15 Million USD | -201.376% |
| Hyperfine, Inc. | -48.11 Million USD | 55.205% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 66.855% |
| Biomerica, Inc. | -6.36 Million USD | -238.511% |
| Bone Biologics Corporation | -9.42 Million USD | -128.599% |
| AVITA Medical, Inc. | -40.4 Million USD | 46.654% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -109.025% |
| Silk Road Medical, Inc | -59.27 Million USD | 63.637% |